These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 15372475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
    Gillgren P, Månsson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U.
    Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
    [Abstract] [Full Text] [Related]

  • 4. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
    Uehara S, Kamo R, Harada T, Ishii M.
    Osaka City Med J; 2009 Jun; 55(1):35-52. PubMed ID: 19725433
    [Abstract] [Full Text] [Related]

  • 5. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS.
    Cancer; 2000 Feb 01; 88(3):589-95. PubMed ID: 10649252
    [Abstract] [Full Text] [Related]

  • 6. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL, Fine JA, Roush GC, Berwick M.
    Cancer; 1996 Aug 01; 78(3):427-32. PubMed ID: 8697387
    [Abstract] [Full Text] [Related]

  • 7. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
    McMullen EA, Kee F, Patterson CC, Gavin AT, Dolan OM.
    Br J Dermatol; 2004 Sep 01; 151(3):587-93. PubMed ID: 15377344
    [Abstract] [Full Text] [Related]

  • 8. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival.
    Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerlöf B, Ringborg UK.
    Cancer; 1999 Oct 01; 86(7):1285-93. PubMed ID: 10506715
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG, Leiter U, Eigentler TK, Garbe C.
    Cancer; 2005 Feb 01; 103(3):616-24. PubMed ID: 15630700
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J, Hansson J, Ingvar C, Månsson-Brahme E, Naredi P, Stierner U, Wagenius G, Lindholm C, Swedish Melanoma Study Group.
    Br J Dermatol; 2013 Apr 01; 168(4):779-86. PubMed ID: 23066913
    [Abstract] [Full Text] [Related]

  • 14. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V, Breuninger H, Garbe C, Moehrle M.
    Br J Dermatol; 2006 Feb 01; 154(2):310-8. PubMed ID: 16433802
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U, Buettner PG, Eigentler TK, Garbe C.
    J Clin Oncol; 2004 Sep 15; 22(18):3660-7. PubMed ID: 15302905
    [Abstract] [Full Text] [Related]

  • 16. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA, Sanders LL, Edwards LJ, Seigler HF, Tyler DS, Grichnik JM.
    Cancer; 2001 Mar 01; 91(5):983-91. PubMed ID: 11251950
    [Abstract] [Full Text] [Related]

  • 17. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D, Borgognoni L, Franchi A, Martini L, Reali UM, Santucci M.
    Melanoma Res; 2000 Apr 01; 10(2):153-64. PubMed ID: 10803716
    [Abstract] [Full Text] [Related]

  • 18. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
    Gimotty PA, Elder DE, Fraker DL, Botbyl J, Sellers K, Elenitsas R, Ming ME, Schuchter L, Spitz FR, Czerniecki BJ, Guerry D.
    J Clin Oncol; 2007 Mar 20; 25(9):1129-34. PubMed ID: 17369575
    [Abstract] [Full Text] [Related]

  • 19. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
    Finley JW, Gibbs JF, Rodriguez LM, Letourneau R, Driscoll D, Kraybill W.
    Am Surg; 2000 Jun 20; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
    [Abstract] [Full Text] [Related]

  • 20. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.
    J Clin Oncol; 2007 Mar 01; 25(7):869-75. PubMed ID: 17327608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.